Bio Path Holdings Stock Technical Analysis
| BPTH Stock | USD 0.07 0.01 16.67% |
As of the 22nd of February, Bio Path shows the Mean Deviation of 5.96, risk adjusted performance of 0.0176, and Downside Deviation of 17.1. Bio Path Holdings technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to interpolate and analyze data for nineteen technical drivers for Bio Path Holdings, which can be compared to its peers.
Bio Path Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Bio, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to BioBio |
Bio Path 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Bio Path's otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Bio Path.
| 11/24/2025 |
| 02/22/2026 |
If you would invest 0.00 in Bio Path on November 24, 2025 and sell it all today you would earn a total of 0.00 from holding Bio Path Holdings or generate 0.0% return on investment in Bio Path over 90 days. Bio Path is related to or competes with Orgenesis, and Helix BioMedix. Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug developmen... More
Bio Path Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Bio Path's otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Bio Path Holdings upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 17.1 | |||
| Information Ratio | 0.0031 | |||
| Maximum Drawdown | 50.79 | |||
| Value At Risk | (16.67) | |||
| Potential Upside | 16.67 |
Bio Path Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bio Path's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Bio Path's standard deviation. In reality, there are many statistical measures that can use Bio Path historical prices to predict the future Bio Path's volatility.| Risk Adjusted Performance | 0.0176 | |||
| Jensen Alpha | 0.3355 | |||
| Total Risk Alpha | (0.85) | |||
| Sortino Ratio | 0.0019 | |||
| Treynor Ratio | (0.03) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bio Path's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Bio Path February 22, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0176 | |||
| Market Risk Adjusted Performance | (0.02) | |||
| Mean Deviation | 5.96 | |||
| Semi Deviation | 7.64 | |||
| Downside Deviation | 17.1 | |||
| Coefficient Of Variation | 9184.01 | |||
| Standard Deviation | 10.34 | |||
| Variance | 106.84 | |||
| Information Ratio | 0.0031 | |||
| Jensen Alpha | 0.3355 | |||
| Total Risk Alpha | (0.85) | |||
| Sortino Ratio | 0.0019 | |||
| Treynor Ratio | (0.03) | |||
| Maximum Drawdown | 50.79 | |||
| Value At Risk | (16.67) | |||
| Potential Upside | 16.67 | |||
| Downside Variance | 292.39 | |||
| Semi Variance | 58.36 | |||
| Expected Short fall | (18.29) | |||
| Skewness | 0.2684 | |||
| Kurtosis | 0.7156 |
Bio Path Holdings Backtested Returns
Bio Path is out of control at the moment. Bio Path Holdings secures Sharpe Ratio (or Efficiency) of 0.0109, which signifies that the company had a 0.0109 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Bio Path Holdings, which you can use to evaluate the volatility of the firm. Please confirm Bio Path's Downside Deviation of 17.1, mean deviation of 5.96, and Risk Adjusted Performance of 0.0176 to double-check if the risk estimate we provide is consistent with the expected return of 0.11%. The firm shows a Beta (market volatility) of -3.3, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Bio Path are expected to decrease by larger amounts. On the other hand, during market turmoil, Bio Path is expected to outperform it. Bio Path Holdings right now shows a risk of 10.34%. Please confirm Bio Path Holdings treynor ratio and the relationship between the semi variance and relative strength index , to decide if Bio Path Holdings will be following its price patterns.
Auto-correlation | -0.04 |
Very weak reverse predictability
Bio Path Holdings has very weak reverse predictability. Overlapping area represents the amount of predictability between Bio Path time series from 24th of November 2025 to 8th of January 2026 and 8th of January 2026 to 22nd of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Bio Path Holdings price movement. The serial correlation of -0.04 indicates that only as little as 4.0% of current Bio Path price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.04 | |
| Spearman Rank Test | -0.25 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Bio Path technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, otc market cycles, or different charting patterns.
Bio Path Holdings Technical Analysis
The output start index for this execution was ten with a total number of output elements of fifty-one. The Normalized Average True Range is used to analyze tradable apportunities for Bio Path Holdings across different markets.
About Bio Path Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Bio Path Holdings on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Bio Path Holdings based on its technical analysis. In general, a bottom-up approach, as applied to this otc stock, focuses on Bio Path Holdings price pattern first instead of the macroeconomic environment surrounding Bio Path Holdings. By analyzing Bio Path's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Bio Path's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Bio Path specific price patterns or momentum indicators. Please read more on our technical analysis page.
Bio Path February 22, 2026 Technical Indicators
Most technical analysis of Bio help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Bio from various momentum indicators to cycle indicators. When you analyze Bio charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0176 | |||
| Market Risk Adjusted Performance | (0.02) | |||
| Mean Deviation | 5.96 | |||
| Semi Deviation | 7.64 | |||
| Downside Deviation | 17.1 | |||
| Coefficient Of Variation | 9184.01 | |||
| Standard Deviation | 10.34 | |||
| Variance | 106.84 | |||
| Information Ratio | 0.0031 | |||
| Jensen Alpha | 0.3355 | |||
| Total Risk Alpha | (0.85) | |||
| Sortino Ratio | 0.0019 | |||
| Treynor Ratio | (0.03) | |||
| Maximum Drawdown | 50.79 | |||
| Value At Risk | (16.67) | |||
| Potential Upside | 16.67 | |||
| Downside Variance | 292.39 | |||
| Semi Variance | 58.36 | |||
| Expected Short fall | (18.29) | |||
| Skewness | 0.2684 | |||
| Kurtosis | 0.7156 |
Bio Path February 22, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Bio stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.00 | ||
| Daily Balance Of Power | Huge | ||
| Rate Of Daily Change | 1.17 | ||
| Day Median Price | 0.07 | ||
| Day Typical Price | 0.07 | ||
| Price Action Indicator | 0.01 |
Complementary Tools for Bio OTC Stock analysis
When running Bio Path's price analysis, check to measure Bio Path's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Path is operating at the current time. Most of Bio Path's value examination focuses on studying past and present price action to predict the probability of Bio Path's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Path's price. Additionally, you may evaluate how the addition of Bio Path to your portfolios can decrease your overall portfolio volatility.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| CEOs Directory Screen CEOs from public companies around the world |